Speaker illustration

Associate Professor Iaroslav Lutay

National Scientific Center "M.D. Strazhesko Institute of cardiology, MAS of Ukraine", Kiev (Ukraine)

Member of:

Heart Failure Association

Early intensive lipid-lowering therapy prevents development of no-reflow phenomenon and reduces the incidence of post MI LV remodeling

Event: ESC CONGRESS 2017

Topic: Infarction acute phase STEMI

Session: STEMI / NSTEMI

Thumbnail

Positive effects of intravenous 5-lipoxygenase inhibitor quercetin in acute ST elevation myocardial infarction: intermediate results of ongoing randomized open blinded multicenter study

Event: Acute Cardiovascular Care 2016

Topic: ST-elevation myocardial infarction - ACS

Session: Acute coronary syndrome - ST-elevation myocardial infarction

Thumbnail

Low dose ezetimibe / atorvastatin combination in acute ST elevation myocardial infarction

Event: Acute Cardiovascular Care 2016

Topic: ST-elevation myocardial infarction - ACS

Session: Acute coronary syndrome - ST-elevation myocardial infarction

Thumbnail

Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.

Event: ESC CONGRESS 2016

Topic: Treatment of hypertension

Session: Hypertension in special conditions

Thumbnail

Effects of intravenous 5-lipoxygenase inhibitor quercetin on endothelial function, systemic inflammation and oxidative stress in acute ST elevation myocardial infarction.

Event: ESC CONGRESS 2016

Topic: Adjunctive medical therapy

Session: Adjunctive medical therapy in coronary artery disease

Thumbnail

Myeloperoxidase concentration is associated with endothelial dysfunction and can be decreased by lipoxygenase inhibitor Quercetin in acute phase of STEMI.

Event: ESC CONGRESS 2016

Topic: Inflammation and microcirculation

Session: Inflammation and immunity

Thumbnail

This platform is supported by

logo Novo Nordisk